FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947487766> ?p ?o ?g. }

• W2947487766 abstract "It has been reported that people living with HIV in West Africa exhibited the highest risks for chronic kidney disease (CKD) in the world. Here, we aimed at determining the CKD frequency and changes in kidney function during antiretroviral treatment (ART) in a large cohort of HIV-patients followed in Burkina Faso.We included ART-naive adults who initiated ART at the Day Care Unit of the Souro Sanou University Hospital between 01/01/2007 and 12/31/2016. We assessed the estimated glomerular filtration rate (eGFR) by serum creatinine using the Modification of Diet in Renal Disease (MDRD) equation. Following the K/DOQI recommendations, CKD was defined as eGFR < 60 ml/min/1.73m2 at two consecutive measurements at least 3 months apart. The factors associated with eGFR decline or CKD were identified by mixed linear regression and Cox regression, respectively.Three thousand, one hundred and thirty-eight patients (72% women) were followed for a median (IQR) of 4.5(2.2-6.9) years. At baseline, median eGFR (IQR) was 110.7(94.4-128.4) ml/min/1.73m2 and 93 (3%) patients exhibited eGFR < 60 ml/min/1.73m2. The lowest-performing progressions of eGFR during the first year of ART were observed in patients with 40-49 yr. age range (- 8.3[- 11.7;-5.0] ml/min/1.73m2, p < 0.001), age ≥ 50 yr. (- 6.2[- 10.7;-1.8] ml/min/1.73m2, p = 0.006) and high blood pressure (HBP) (- 28.4[- 46.9;-9.9] ml/min/1.73m2, p = 0.003) at ART initiation. Regarding the ART exposure in patients with normal baseline eGFR, zidovudine (AZT) with protease inhibitor (PI) (- 4.7[- 7.7;-1.6] ml/min/1.73m2, p = 0.002), tenofovir (TDF) + PI (- 13.1[- 17.4;-8.7] ml/min/1.73m2, p < 0.001), TDF without PI (- 3.2[- 5.0;-1.4] ml/min/1.73m2, p < 0.001), stavudine (d4T) + PI (- 8.5[- 14.6-2.4] ml/min/1.73m2, p = 0.006) and d4T without PI (- 5.0[- 7.6-2.4] ml/min/1.73m2, p < 0.001) were associated with poorer eGFR progression. The prevalence of CKD was 0.5% and the incidence was 1.9 [1.3; 2.7] cases/1000 person-years. The risk of CKD was higher in patients with HBP (4.3[1.8;9.9], p = 0.001), 40-49 yr. patients (4.2[1.6;11.2], p = 0.004), ≥50 yr. patients (4.5[1.5;14.1], p = 0.009) and patients exposed to abacavir (ABC) or didanosine (ddI) based ART (13.1[4.0;42.9], p < 0.001).Our findings do not confirm the high risk of CKD reported in previous studies of West Africans with HIV, but support the recommendations for early initiation of ART and close kidney function monitoring in patients with HBP or aged ≥40 yr." @default.
• W2947487766 created "2019-06-07" @default.
• W2947487766 creator A5005446989 @default.
• W2947487766 creator A5012477130 @default.
• W2947487766 creator A5025754562 @default.
• W2947487766 creator A5026636746 @default.
• W2947487766 creator A5026646836 @default.
• W2947487766 creator A5029221966 @default.
• W2947487766 creator A5034222172 @default.
• W2947487766 creator A5040608842 @default.
• W2947487766 creator A5057063846 @default.
• W2947487766 creator A5074518938 @default.
• W2947487766 creator A5075931545 @default.
• W2947487766 creator A5082182356 @default.
• W2947487766 date "2019-05-07" @default.
• W2947487766 modified "2023-10-07" @default.
• W2947487766 title "Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting" @default.
• W2947487766 cites W182887971 @default.
• W2947487766 cites W1904635711 @default.
• W2947487766 cites W1914996640 @default.
• W2947487766 cites W1966715536 @default.
• W2947487766 cites W1967879506 @default.
• W2947487766 cites W1971384013 @default.
• W2947487766 cites W1972696131 @default.
• W2947487766 cites W1973918976 @default.
• W2947487766 cites W1977978002 @default.
• W2947487766 cites W1981564915 @default.
• W2947487766 cites W1985198441 @default.
• W2947487766 cites W2017667056 @default.
• W2947487766 cites W2018901137 @default.
• W2947487766 cites W2023206926 @default.
• W2947487766 cites W2024163727 @default.
• W2947487766 cites W2032683066 @default.
• W2947487766 cites W2049958520 @default.
• W2947487766 cites W2078742538 @default.
• W2947487766 cites W2080152031 @default.
• W2947487766 cites W2099120782 @default.
• W2947487766 cites W2101483113 @default.
• W2947487766 cites W2112311783 @default.
• W2947487766 cites W2118020641 @default.
• W2947487766 cites W2137927646 @default.
• W2947487766 cites W2140009647 @default.
• W2947487766 cites W2140577591 @default.
• W2947487766 cites W2146105386 @default.
• W2947487766 cites W2147020182 @default.
• W2947487766 cites W2148228968 @default.
• W2947487766 cites W2149717057 @default.
• W2947487766 cites W2152470009 @default.
• W2947487766 cites W2154161789 @default.
• W2947487766 cites W2162761942 @default.
• W2947487766 cites W2174752775 @default.
• W2947487766 cites W2207187448 @default.
• W2947487766 cites W2318462211 @default.
• W2947487766 cites W2351597996 @default.
• W2947487766 cites W2555487083 @default.
• W2947487766 cites W2606227835 @default.
• W2947487766 cites W2607031541 @default.
• W2947487766 cites W2618258744 @default.
• W2947487766 cites W2767300162 @default.
• W2947487766 cites W2794276766 @default.
• W2947487766 cites W2801192496 @default.
• W2947487766 cites W2802589557 @default.
• W2947487766 cites W2804490940 @default.
• W2947487766 cites W2884072171 @default.
• W2947487766 cites W4211025575 @default.
• W2947487766 doi "https://doi.org/10.1186/s12882-019-1335-9" @default.
• W2947487766 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6505177" @default.
• W2947487766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31064340" @default.
• W2947487766 hasPublicationYear "2019" @default.
• W2947487766 type Work @default.
• W2947487766 sameAs 2947487766 @default.
• W2947487766 citedByCount "17" @default.
• W2947487766 countsByYear W29474877662020 @default.
• W2947487766 countsByYear W29474877662021 @default.
• W2947487766 countsByYear W29474877662022 @default.
• W2947487766 countsByYear W29474877662023 @default.
• W2947487766 crossrefType "journal-article" @default.
• W2947487766 hasAuthorship W2947487766A5005446989 @default.
• W2947487766 hasAuthorship W2947487766A5012477130 @default.
• W2947487766 hasAuthorship W2947487766A5025754562 @default.
• W2947487766 hasAuthorship W2947487766A5026636746 @default.
• W2947487766 hasAuthorship W2947487766A5026646836 @default.
• W2947487766 hasAuthorship W2947487766A5029221966 @default.
• W2947487766 hasAuthorship W2947487766A5034222172 @default.
• W2947487766 hasAuthorship W2947487766A5040608842 @default.
• W2947487766 hasAuthorship W2947487766A5057063846 @default.
• W2947487766 hasAuthorship W2947487766A5074518938 @default.
• W2947487766 hasAuthorship W2947487766A5075931545 @default.
• W2947487766 hasAuthorship W2947487766A5082182356 @default.
• W2947487766 hasBestOaLocation W29474877661 @default.
• W2947487766 hasConcept C126322002 @default.
• W2947487766 hasConcept C126894567 @default.
• W2947487766 hasConcept C159641895 @default.
• W2947487766 hasConcept C201903717 @default.
• W2947487766 hasConcept C2778653478 @default.
• W2947487766 hasConcept C2780306776 @default.
• W2947487766 hasConcept C50382708 @default.
• W2947487766 hasConcept C54847362 @default.
• W2947487766 hasConcept C71924100 @default.
• W2947487766 hasConcept C72563966 @default.

• next